Syngenic Bone Graft
Syngenic Bone Graft - Related Videos
06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
0 Views •
Cited by 14 •
2020
Bone metastasis models do not develop metastasis uniformly or with a 100% incidence. Direct intra-osseous tumor cell injection can result in embolization of the lung. We present our technique modeling primary bone tumors and bone metastasis using solid tumor graft implantation into bone, leading to reproducible engraftment and growth.
05:54
Induction of Graft Versus Host Disease in Mouse Models via Allogeneic Bone Marrow and Splenic Cell Transplantation
0 Views •
2025
This video demonstrates the induction of intestinal graft-versus-host disease, GvHD, in a lethally-irradiated recipient mouse using allogeneic hematopoietic stem cells and GvHD-inducing splenic alloreactive T lymphocytes. This protocol helps establish a severe acute intestinal GvHD model to understand the mechanism of the disease and develop innovative therapeutic options.
11:20
A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
0 Views •
2022
We demonstrate how to establish a murine model of pulmonary root implantation into the descending aorta to simulate the Ross procedure. This model enables the medium/long-term evaluation of pulmonary autograft remodeling in a systemic position, representing the basis of developing therapeutic strategies to promote its adaptation.
03:57
In Vitro Mineralization Assay: A Colorimetric Method to Quantify Osteoblast Calcium Deposits on Bone Graft Substitute by Alizarin Red S Staining and Extraction
0 Views •
2025
In this video, we describe a method for the detection of osteoblast-secreted calcium deposits using an anionic dye, Alizarin Red S. The cultured osteoblasts are first stained and then the dye is recovered for colorimetric quantification of calcium deposits or the degree of osteoblast mineralization.
05:06
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
0 Views •
Cited by 2 •
2015
The metastatic spread of cancer is the major cause of cancer-related deaths. We provide an in-depth description of our survival surgery methodology for establishing a “patient-like” orthotopic syngeneic mouse model system for studying the mechanisms of metastasis in solid organ tumors.
FAQs
Shared major histocompatibility antigens reduce the likelihood that the recipient’s immune system will recognize the transplanted bone as strongly foreign. This minimizes immunologic complications that can interfere with graft incorporation, allowing attention to remain on how the graft integrates with the recipient’s skeleton. The mechanism is especially useful when studying bone repair without a prominent rejection response.
Immune compatibility helps distinguish biological repair from complications caused by tissue rejection. In a syngenic bone graft model, the limited immune mismatch reduces one major source of experimental variation, making graft incorporation and skeletal healing easier to examine. This allows researchers to focus more directly on regeneration-related processes rather than interpreting whether poor repair reflects immune incompatibility.
The central difference is the strength of the expected immune response. Genetically mismatched tissue can provoke stronger recognition by the recipient’s immune system, whereas shared major histocompatibility antigens in a syngenic graft generally minimize that response. Consequently, the syngenic setting is useful for evaluating skeletal repair while reducing the confounding influence of immune rejection.
Identical twins and genetically matched laboratory animals provide donor-recipient pairs with essentially the same major histocompatibility antigens. That genetic match creates a controlled setting for examining graft incorporation and bone healing. In laboratory research, the model can therefore help separate intrinsic repair mechanisms from outcomes that would otherwise be influenced by genetic incompatibility between the donor and recipient.
Researchers can use incorporation outcomes to investigate how transplanted bone becomes integrated with the recipient’s skeleton and how skeletal defects undergo repair. Because strong immune rejection is minimized, observations can more closely reflect biological healing and tissue regeneration. The model therefore supports focused study of repair mechanisms that might be obscured when immunologic complications are prominent.
In reconstruction research, this model provides a way to examine skeletal repair under conditions that limit immune-related interference. Investigators can assess graft incorporation and regeneration as biological processes, then use those observations to inform broader studies of repairing skeletal defects. Its value lies in clarifying repair behavior before complications associated with genetically mismatched tissue are considered.